Liposome-mediated DNA vaccination: The effect of vesicle composition

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3301-3310

  Perrie, Yvonne ^a,b   Frederik, Peter M ^c   Gregoriadis, Gregory ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Lipoxen Technologies Ltd   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

DNA vaccines; Hepatitis B surface antigen; Liposomes; Plasmid DNA

Indexed keywords

CHOLESTEROL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DISTEAROYLPHOSPHATIDYLCHOLINE; DNA VACCINE; GREEN FLUORESCENT PROTEIN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PLASMID DNA; TRIMETHYLAMMONIUM SALT DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA CONTENT; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LIPID COMPOSITION; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE;

ANIMALS; CRYOELECTRON MICROSCOPY; DRUG CARRIERS; ELECTROCHEMISTRY; FATTY ACIDS, MONOUNSATURATED; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; INJECTIONS, INTRAMUSCULAR; LIPOSOMES; MICE; MICE, INBRED BALB C; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS; VACCINES, DNA;

EID: 0035971971     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00432-1     Document Type: Article

References (46)

1. Heterologous protection against influenza by injection of DNA encoding a viral protein
2. DNA vaccines: A review
3. Genetic vaccines: Strategies for optimisation
4. Direct gene transfer in skeletal muscle in vivo: Factors influencing efficiency of transfer and stability of expression
5. Genetic immunisation is a simple method for eliciting an immune response
6. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen presenting cells
7. DNA vaccination: Protective immunizations by parenteral, mucosal and gene-gun inoculations
8. Mucosal immunization with DNA-liposome complexes
9. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1
10. Liposome-mediated gene transfer
11. Immunisation with DNA, adenovirus or both in biodegradable alginate microspheres: Effect of route of inoculation on immune response
12. Cationic microparticles: A potent delivery system for DNA vaccines
13. Attenuated Shigella as a DNA delivery vehicle for DNA mediated immunization
14. The immune response to a polyoma virus replicon-based DNA vaccine
15. Liposome-mediated DNA vaccination
16. Entrapment of plasmid DNA vaccines into liposomes by dehydration/rehydration
17. Liposomes as immunological adjuvants and vaccine carriers
18. High yield incorporation of plasmid DNA within liposomes: Effect on DNA intergrity and transfection
19. Liposome-entrapped plasmid DNA: Characterisation studies
20. Fate of cholesterol-rich unilamellar liposomes containing 111-I-labelled bleomycin after subcutaneous injection into rats
21. Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats
22. Immunological adjuvants: A role for liposomes
23. Dehydration-rehydration vesicles: A simple method for high yield drug entrapment in liposomes
24. Morphological observations on liposomes bearing covalently bound protein: Studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques
25. Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice
26. Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant
27. Coupling of ligands to liposomes independently of solute entrapment: Observations on the formed vesicles
28. Characterization of DNA-lipid complexes commonly used for gene delivery
29. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems
30. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gen transfer
31. Enhanced gene delivery and mechanism studies with a novel series of cationic formulations
32. Fusion of cationic liposomes with mammalian cells occurs after endocytosis
33. pH-induced destabilisation of phosphatidylethanolamine-containing liposomes: Role of bilayer contact
34. pH-sensitive immunoliposomes as an efficient and target specific carrier for antitumour drugs
35. Lipid polymorphism and the roles of lipid membranes
36. Membrane fusion
37. How are nucleic acids released in cells from cationic lipid-nucleic acid complexes?
38. Correlation between physicochemical characteristics of synthetic cationic amphiphiles and their DNA transfection ability
39. Fusion of liposomes containing a novel cationic lipid, N-[2,3-(diolelyoxy)propyl]-N,N,N-trimethylammonium:Induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles
40. Liposomes as immunological adjuvants: Antigen incorporation studies
41. Lipidic supramolecular assemblies for gene transfer
42. Interaction of liposomes with blood plasma proteins
43. Lipofection: A highly efficient, lipid-mediated DNA- transfection procedure
44. Cationic liposomes as an oligonucleotide carrier: Mechanism of action
45. Genetic immunisation using liposome incorporated DNA
46. The effect of cationic lipid content on the physicochemical characteristics of liposome-entrapped DNA